Research Institute By the Numbers

With a budget of $928M in 2018, Mass General is home to the largest hospital-based research enterprise in the United State. Mass General ranks 1st among independent hospitals in the amount of annual funding received from NIH, and it ranks 8th among all institutions.

Research at Mass General takes place in 30 departments, centers and institutes across the hospital. The Department of Medicine has the largest research portfolio at 21% of the total. We also have significant research programs taking place in our Thematic Research Center (13%), the Mass General Cancer Center (11%), Neurology (11%), Radiology 10%), Surgery (6%) and Psychiatry (6%), as well as many others.

The research community includes more than 8,500 people and covers 1.2M square feet of research space in Boston, Cambridge and Charlestown. We have 2,000 principal investigators and there are 1,500 postdoctoral fellows and 700 graduate students training in research at Mass General at any given time. Over one-third of the 3,000 physicians at Mass General are also conducting research.

To date, more than 85,000 patients have consented to have their blood samples and health histories added to the Partners Biobank at MGH, so we can learn more about the genetic basis of disease

The Office of the Scientific Director has established the Mass General Research Institute Blog to promote the work of investigators at Massachusetts General Hospital. Since its launch in 2017, the blog has received more than 44,000 views from 32,000 visitors.

Since the inception of the MGH Research Scholars program in 2011, a total of 55 Mass General investigators have received crucial unrestricted funding ($100,000 per year for five years) to support the game-changing ideas that are too early or unproven for traditional forms of funding.


 

Mass General OutcomesFY14FY15FY16

Licensing Activity

113

127

130

Material Transfer Agreements

1,073

987

1067

New Disclosures

408

318

365

Patents Filed (US)

253

228

528

Patents Filed (Int’l)

644

399

382

Patients Issued (US)

86

89

109

Patients Issued (Int’l)

172

120

190

Royalty and Licensing Income

$68.9M

$80M

$77M

Back to Top